Serveur d'exploration H2N2

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

In silico analysis of drug-resistant mutant of neuraminidase (N294S) against oseltamivir

Identifieur interne : 000B21 ( Main/Exploration ); précédent : 000B20; suivant : 000B22

In silico analysis of drug-resistant mutant of neuraminidase (N294S) against oseltamivir

Auteurs : V. Karthick [Inde] ; V. Shanthi [Inde] ; R. Rajasekaran [Inde] ; K. Ramanathan [Inde]

Source :

RBID : ISTEX:231846102B7C328F81384CB489C765297DD14409

English descriptors

Abstract

Abstract: The recent H1N1 influenza pandemic has attracted worldwide attention due to the high infection rate. Oseltamivir is a new class of anti-viral agent approved for the treatment and prevention of influenza infections. The principal target for this drug is a virus surface glycoprotein, neuraminidase (NA), which facilitates the release of nascent virus and thus spreads infection. Until recently, only a low prevalence of neuraminidase inhibitor (NAI) resistance (<1 %) had been detected in circulating viruses. However, there have been reports of significant numbers of A (H1N1) influenza strains with a N294S neuraminidase mutation that was highly resistant to the NAI, oseltamivir. Hence, in the present study, we highlight the effect of point mutation-induced oseltamivir resistance in H1N1 subtype neuraminidases by molecular simulation approach. The docking analysis reveals that mutation (N294S) significantly affects the binding affinity of oseltamivir with mutant type NA. This is mainly due to the decrease in the flexibility of binding site residues and the difference in prevalence of hydrogen bonds in the wild and mutant structures. This study throws light on the possible effects of drug-resistant mutations on the large functionally important collective motions in biological systems.

Url:
DOI: 10.1007/s00709-012-0394-6


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">In silico analysis of drug-resistant mutant of neuraminidase (N294S) against oseltamivir</title>
<author>
<name sortKey="Karthick, V" sort="Karthick, V" uniqKey="Karthick V" first="V." last="Karthick">V. Karthick</name>
</author>
<author>
<name sortKey="Shanthi, V" sort="Shanthi, V" uniqKey="Shanthi V" first="V." last="Shanthi">V. Shanthi</name>
</author>
<author>
<name sortKey="Rajasekaran, R" sort="Rajasekaran, R" uniqKey="Rajasekaran R" first="R." last="Rajasekaran">R. Rajasekaran</name>
</author>
<author>
<name sortKey="Ramanathan, K" sort="Ramanathan, K" uniqKey="Ramanathan K" first="K." last="Ramanathan">K. Ramanathan</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:231846102B7C328F81384CB489C765297DD14409</idno>
<date when="2012" year="2012">2012</date>
<idno type="doi">10.1007/s00709-012-0394-6</idno>
<idno type="url">https://api.istex.fr/ark:/67375/VQC-3LDJRL57-9/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001100</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001100</idno>
<idno type="wicri:Area/Istex/Curation">001100</idno>
<idno type="wicri:Area/Istex/Checkpoint">000098</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000098</idno>
<idno type="wicri:doubleKey">0033-183X:2012:Karthick V:in:silico:analysis</idno>
<idno type="wicri:Area/Main/Merge">000B24</idno>
<idno type="wicri:Area/Main/Curation">000B21</idno>
<idno type="wicri:Area/Main/Exploration">000B21</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">In silico analysis of drug-resistant mutant of neuraminidase (N294S) against oseltamivir</title>
<author>
<name sortKey="Karthick, V" sort="Karthick, V" uniqKey="Karthick V" first="V." last="Karthick">V. Karthick</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Bioinformatics Division, School of Bio Sciences and Technology, Vellore Institute of Technology, 632014, Vellore, Tamil Nadu</wicri:regionArea>
<wicri:noRegion>Tamil Nadu</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Shanthi, V" sort="Shanthi, V" uniqKey="Shanthi V" first="V." last="Shanthi">V. Shanthi</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Industrial Biotechnology Division, School of Bio Sciences and Technology, Vellore Institute of Technology, 632014, Vellore, Tamil Nadu</wicri:regionArea>
<wicri:noRegion>Tamil Nadu</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Rajasekaran, R" sort="Rajasekaran, R" uniqKey="Rajasekaran R" first="R." last="Rajasekaran">R. Rajasekaran</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Bioinformatics Division, School of Bio Sciences and Technology, Vellore Institute of Technology, 632014, Vellore, Tamil Nadu</wicri:regionArea>
<wicri:noRegion>Tamil Nadu</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">Inde</country>
</affiliation>
</author>
<author>
<name sortKey="Ramanathan, K" sort="Ramanathan, K" uniqKey="Ramanathan K" first="K." last="Ramanathan">K. Ramanathan</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Bioinformatics Division, School of Bio Sciences and Technology, Vellore Institute of Technology, 632014, Vellore, Tamil Nadu</wicri:regionArea>
<wicri:noRegion>Tamil Nadu</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">Inde</country>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Protoplasma</title>
<title level="j" type="sub">An International Journal of Cell Biology</title>
<title level="j" type="abbrev">Protoplasma</title>
<idno type="ISSN">0033-183X</idno>
<idno type="eISSN">1615-6102</idno>
<imprint>
<publisher>Springer Vienna</publisher>
<pubPlace>Vienna</pubPlace>
<date type="published" when="2013-02-01">2013-02-01</date>
<biblScope unit="volume">250</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="197">197</biblScope>
<biblScope unit="page" to="207">207</biblScope>
</imprint>
<idno type="ISSN">0033-183X</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0033-183X</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Molecular docking</term>
<term>Molecular dynamic simulation</term>
<term>Neuraminidase</term>
<term>Normal mode analysis</term>
<term>Oseltamivir resistance</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: The recent H1N1 influenza pandemic has attracted worldwide attention due to the high infection rate. Oseltamivir is a new class of anti-viral agent approved for the treatment and prevention of influenza infections. The principal target for this drug is a virus surface glycoprotein, neuraminidase (NA), which facilitates the release of nascent virus and thus spreads infection. Until recently, only a low prevalence of neuraminidase inhibitor (NAI) resistance (<1 %) had been detected in circulating viruses. However, there have been reports of significant numbers of A (H1N1) influenza strains with a N294S neuraminidase mutation that was highly resistant to the NAI, oseltamivir. Hence, in the present study, we highlight the effect of point mutation-induced oseltamivir resistance in H1N1 subtype neuraminidases by molecular simulation approach. The docking analysis reveals that mutation (N294S) significantly affects the binding affinity of oseltamivir with mutant type NA. This is mainly due to the decrease in the flexibility of binding site residues and the difference in prevalence of hydrogen bonds in the wild and mutant structures. This study throws light on the possible effects of drug-resistant mutations on the large functionally important collective motions in biological systems.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Inde</li>
</country>
</list>
<tree>
<country name="Inde">
<noRegion>
<name sortKey="Karthick, V" sort="Karthick, V" uniqKey="Karthick V" first="V." last="Karthick">V. Karthick</name>
</noRegion>
<name sortKey="Rajasekaran, R" sort="Rajasekaran, R" uniqKey="Rajasekaran R" first="R." last="Rajasekaran">R. Rajasekaran</name>
<name sortKey="Rajasekaran, R" sort="Rajasekaran, R" uniqKey="Rajasekaran R" first="R." last="Rajasekaran">R. Rajasekaran</name>
<name sortKey="Ramanathan, K" sort="Ramanathan, K" uniqKey="Ramanathan K" first="K." last="Ramanathan">K. Ramanathan</name>
<name sortKey="Ramanathan, K" sort="Ramanathan, K" uniqKey="Ramanathan K" first="K." last="Ramanathan">K. Ramanathan</name>
<name sortKey="Shanthi, V" sort="Shanthi, V" uniqKey="Shanthi V" first="V." last="Shanthi">V. Shanthi</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B21 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000B21 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:231846102B7C328F81384CB489C765297DD14409
   |texte=   In silico analysis of drug-resistant mutant of neuraminidase (N294S) against oseltamivir
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021